Literature DB >> 8182153

Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.

H Shimano1, Y Namba, J Ohsuga, M Kawamura, K Yamamoto, M Shimada, T Gotoda, K Harada, Y Yazaki, N Yamada.   

Abstract

To investigate the role of apoE in hepatic uptake of chylomicron remnants, we studied chylomicron metabolism in transgenic mice overexpressing apoE in the liver. Plasma clearance of injected 125I-labeled human chylomicrons was fivefold faster in transgenic mice than in controls. Immunohistochemistry demonstrated that apoE was specifically localized at the basolateral surface of hepatocytes from fasted transgenic mice. After injection of a large amount of chylomicrons, the density of the cell surface apoE was markedly reduced and vesicular staining was observed in the cytoplasm, suggesting that the cell surface apoE was used for hepatic endocytosis of chylomicrons and remnants. Polyacrylamide gel analysis of chylomicrons and remnants that had been reisolated from plasma and from liver membrane after the injection of chylomicrons showed the particles to be enriched with apoE mainly after their influx into the liver rather than during their residence in plasma. These results provide strong evidence for the secretion-recapture process of apoE, whereby chylomicron remnants enter the sinusoidal space, acquire apoE molecules, and subsequently are endocytosed. Data from experiments with very low density lipoprotein and LDL showed that this system is specific for chylomicron remnants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182153      PMCID: PMC294368          DOI: 10.1172/JCI117218

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.

Authors:  H Shimano; N Yamada; M Katsuki; K Yamamoto; T Gotoda; K Harada; M Shimada; Y Yazaki
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

3.  Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc.

Authors:  R E Pitas; T L Innerarity; K S Arnold; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Regulation of the hepatic removal of chylomicron remnants and beta-very low density lipoproteins in the rat.

Authors:  S Jäckle; F Rinninger; J Greeve; H Greten; E Windler
Journal:  J Lipid Res       Date:  1992-03       Impact factor: 5.922

6.  Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.

Authors:  Z S Ji; W J Brecht; R D Miranda; M M Hussain; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

7.  Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins.

Authors:  K Imaizumi; M Fainaru; R J Havel
Journal:  J Lipid Res       Date:  1978-08       Impact factor: 5.922

8.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

Authors:  U Beisiegel; W Weber; G Bengtsson-Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.

Authors:  M Mulder; P Lombardi; H Jansen; T J van Berkel; R R Frants; L M Havekes
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

10.  The effect of apo E secretion on lipoprotein uptake in transfected cells.

Authors:  H Shimano; C Fukazawa; Y Shibasaki; N Mori; T Gotoda; K Harada; M Shimada; N Yamada; Y Yazaki; F Takaku
Journal:  Biochim Biophys Acta       Date:  1991-11-27
View more
  10 in total

1.  Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.

Authors:  Robert W Mahley; Yadong Huang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.

Authors:  M F Linton; A H Hasty; V R Babaev; S Fazio
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

3.  Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.

Authors:  J D Medh; G L Fry; S L Bowen; S Ruben; H Wong; D A Chappell
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

Review 4.  Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models.

Authors:  K W van Dijk; M H Hofker; L M Havekes
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

5.  Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.

Authors:  M C Jong; V E Dahlmans; M H Hofker; L M Havekes
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

Review 6.  Vitamin K nutrition, metabolism, and requirements: current concepts and future research.

Authors:  Martin J Shearer; Xueyan Fu; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

7.  In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.

Authors:  M C Jong; V E Dahlmans; P J van Gorp; K W van Dijk; M L Breuer; M H Hofker; L M Havekes
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

8.  Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice.

Authors:  Michael Altenburg; Jose Arbones-Mainar; Lance Johnson; Jennifer Wilder; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-27       Impact factor: 8.311

9.  Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E.

Authors:  J Osuga; M Yonemoto; N Yamada; H Shimano; H Yagyu; K Ohashi; K Harada; T Kamei; Y Yazaki; S Ishibashi
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

10.  Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.

Authors:  H Shimano; J Ohsuga; M Shimada; Y Namba; T Gotoda; K Harada; M Katsuki; Y Yazaki; N Yamada
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.